Actively Recruiting
Diagnosis and Treatment of Sleep Apnea in Shelter Residents Using Portable Polysomnography and Patient-Centered Treatment
Led by University Health Network, Toronto · Updated on 2024-10-01
100
Participants Needed
2
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying sleep apnea in people experiencing homelessness who live in shelters. Sleep apnea is a condition where breathing stops and starts during sleep, causing fatigue and low quality of life. This population may have a higher rate of undiagnosed sleep apnea due to barriers in healthcare access. The study aims to diagnose and treat sleep apnea using technology and telemedicine to improve quality of life and health outcomes for shelter residents. Participants will have their sleep apnea assessed using a portable polysomnography device called Prodigy 2, which measures breathing, heart function, oxygen levels, and sleep stages overnight. Those diagnosed with sleep apnea and eligible for treatment will be offered options including auto-titrating CPAP or a mandibular advancement device based on clinical guidelines and personal preferences. Participants will also complete several questionnaires related to sleep, fatigue, depression, asthma control, and other health factors. Throughout the study, researchers will monitor sleep data, apnea severity, treatment adherence, and quality of life changes over a period of up to six months after starting treatment. They will assess outcomes such as apnea prevalence, sleep-related quality of life, blood pressure effects, and factors influencing treatment use. The study will last up to four years and includes safety monitoring and follow-up visits to better understand sleep apnea in this vulnerable group.
CONDITIONS
Brief Title
Digital Technology for Sleep and Homelessness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Residing in a shelter at the time of recruitment
- Age over 18 years old
You will not qualify if you...
- Allergies to medical tape for the diagnosis study
- Requiring extensive dental treatment or having periodontal disease with tooth mobility for the treatment study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 night for polysomnography and one session for questionnaires
Participants undergo an overnight sleep study using a portable polysomnography device to assess for obstructive sleep apnea. They also complete questionnaires with the help of a research assistant to evaluate sleep, health, and related conditions.
1 baseline visit (in-person) and 1 overnight sleep study
Duration - 6 months
Participants diagnosed with sleep apnea receive patient-centered treatment using either Auto-CPAP or a mandibular advancement device (MAD) based on physician recommendations and participant preference.
Visits as needed for treatment initiation and follow-up
Duration - Up to 6 months after starting treatment
Participants are monitored to assess treatment effects on sleep-related quality of life, blood pressure, and treatment adherence over time.
Visits at 3 and 6 months post-treatment start
Trial Site Locations
Total: 2 locations
1
Dixon Hall
Toronto, Ontario, Canada, M4C 1L7
Actively Recruiting
2
Fred Victor
Toronto, Ontario, Canada, M5S 3A9
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here